Clinical Trial Update: Study of TP-04 in Participants With Papulopustular Rosacea [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for TP-04 in participants with papulopustular rosacea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Papulopustular Rosacea

Drugs mentioned

• TP-04

Snippet

Sponsor: Tarsus Pharmaceuticals, Inc. | Conditions: Papulopustular Rosacea | Phase 2 | Status: COMPLETED